|
C5ORF25 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.014600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.484470E-02 |
| Normal-vs-Stage2 |
4.993200E-01 |
| Normal-vs-Stage3 |
7.717400E-01 |
| Normal-vs-Stage4 |
9.218200E-01 |
| Stage1-vs-Stage2 |
5.066400E-02 |
| Stage1-vs-Stage3 |
5.272400E-02 |
| Stage1-vs-Stage4 |
3.832000E-02 |
| Stage2-vs-Stage3 |
4.061600E-01 |
| Stage2-vs-Stage4 |
5.774400E-01 |
| Stage3-vs-Stage4 |
7.386600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.288400E-01 |
| Normal-vs-AfricanAmerican |
1.007590E-01 |
| Normal-vs-Asian |
3.381200E-01 |
| Caucasian-vs-AfricanAmerican |
3.903600E-01 |
| Caucasian-vs-Asian |
3.515600E-01 |
| AfricanAmerican-vs-Asian |
1.320770E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.986600E-01 |
| Normal-vs-Female |
5.291700E-02 |
| Male-vs-Female |
1.283800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.010400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.617000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.305620E-01 |
| Normal-vs-Age(81-100Yrs) |
5.073000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.957400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.516600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.335200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.212600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.010600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.892800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.194000E-04 |
| Normal-vs-Grade 2 |
4.137900E-02 |
| Normal-vs-Grade 3 |
3.895600E-01 |
| Normal-vs-Grade 4 |
1.147000E-01 |
| Grade 1-vs-Grade 2 |
2.162200E-02 |
| Grade 1-vs-Grade 3 |
4.517400E-03 |
| Grade 1-vs-Grade 4 |
1.023330E-03 |
| Grade 2-vs-Grade 3 |
2.057200E-01 |
| Grade 2-vs-Grade 4 |
2.335000E-03 |
| Grade 3-vs-Grade 4 |
2.376400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.10659999999585E-06 |
| Normal-vs-ccB subtype |
8.375200E-04 |
| ccA subtype-vs-ccB subtype |
1.11022302462516E-16 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.418800E-01 |
| Normal-vs-N1 |
6.348400E-02 |
| N0-vs-N1 |
5.891800E-02 |
|
|
